Solo educación · requiere revisión profesional
Pentadeca-arginate · The "BPC-157 alternative", examined
A newer synthetic peptide marketed as a replacement — with less published research than the original.
Revisado médicamente por Bernard Garcia, MD
Qué es
Pentadeca-arginate (PDA) is a synthetic peptide with a sequence closely related to BPC-157, marketed after regulators restricted compounding of BPC-157. It is discussed in the same soft-tissue and gut contexts.
The important fact: the published research base for PDA is smaller than BPC-157's already-limited human evidence. Most claims are extrapolated from BPC-157 studies.
Cómo funciona
Proposed mechanisms mirror those described for BPC-157 in animal models. Independent peer-reviewed studies specific to PDA are few. A provider will be honest that this is a substitution driven by regulation, not evidence.
Estado de la investigación
| Área de investigación | Estado |
|---|---|
| Soft-tissue repair research | Preclinical, largely extrapolated from BPC-157 |
| Gastrointestinal research | Preclinical, extrapolated |
| Human clinical trials | None published |
| Regulatory status (US FDA) | Not an FDA-approved drug |
El estado refleja únicamente el contexto de la investigación publicada y no constituye una afirmación de seguridad, eficacia o idoneidad para ninguna persona.
¿Es legal?
In the United States this compound is not an FDA-approved drug for any use. It is not lawfully sold for human use as a "research chemical", and whether a licensed provider can consider it depends on federal compounding rules and state law, both of which change. This is a general note, not legal advice.
Preguntas frecuentes
Is PDA the same as BPC-157?
No. It is a related but distinct sequence. Studies of BPC-157 do not automatically apply.
Why did it appear?
After the FDA placed BPC-157 in Category 2 for compounding in 2023, some compounders and sellers moved to PDA as a substitute.
Is it safer?
Unknown. Less research means less known about safety, not more.
Siguiente paso
Siguiente paso: una consulta confidencial de 3 minutos, revisada por un profesional con licencia. No se promete ni se da a entender ningún tratamiento.
Gratis · unos 10 minutos · revisado por un médico con licencia
Educación general · No es consejo médico · Se requiere aprobación profesional